ทวีตที่ปักหมุด

General #SB623 update. First or FYI, company, partnerships, and SB623 R & D status @ sanbio.com. #TBI phase 2b achieved primary endpoint, while #ChronicIschemicStroke phase 2b did not meet primary endpoint. Even so, no safety issues thus far <sanbio.com/wp/wp-content/…>
English

































